LIF and familial pancreatic carcinoma: The results showed that the phosphorylation level of STAT3 in pancreatic cancer cells was significantly downregulated after adding the LIF inhibitor, and the downregulation became more significant as the inhibitor concentration increased (Figure 7A,B).